Shares of Tilray Inc (NASDAQ:TLRY - Get Free Report) saw unusually-strong trading volume on Monday . Approximately 20,281,904 shares changed hands during mid-day trading, a decline of 19% from the previous session's volume of 24,941,295 shares.The stock last traded at $1.80 and had previously closed at $1.64.
Analysts Set New Price Targets
Separately, Roth Mkm dropped their price target on Tilray from $2.00 to $1.75 and set a "neutral" rating for the company in a report on Friday, October 11th.
Read Our Latest Stock Report on TLRY
Tilray Trading Up 5.5 %
The company has a current ratio of 2.47, a quick ratio of 1.57 and a debt-to-equity ratio of 0.08. The stock has a market capitalization of $1.56 billion, a P/E ratio of -6.41 and a beta of 2.14. The business has a 50-day moving average price of $1.69 and a two-hundred day moving average price of $1.79.
Tilray (NASDAQ:TLRY - Get Free Report) last announced its quarterly earnings data on Thursday, October 10th. The company reported ($0.04) EPS for the quarter, meeting the consensus estimate of ($0.04). Tilray had a negative net margin of 26.79% and a negative return on equity of 2.00%. The business had revenue of $200.00 million during the quarter, compared to the consensus estimate of $218.70 million. During the same period in the previous year, the business earned ($0.10) earnings per share. The company's revenue was up 13.0% on a year-over-year basis. On average, analysts expect that Tilray Inc will post -0.14 EPS for the current fiscal year.
Hedge Funds Weigh In On Tilray
Institutional investors have recently added to or reduced their stakes in the stock. HBK Sorce Advisory LLC bought a new position in Tilray during the 1st quarter worth $37,000. Prospect Financial Services LLC bought a new stake in shares of Tilray in the 2nd quarter valued at $26,000. Signature Estate & Investment Advisors LLC acquired a new stake in shares of Tilray during the second quarter worth $29,000. Essex LLC acquired a new position in Tilray in the first quarter valued at $49,000. Finally, Jeppson Wealth Management LLC bought a new stake in Tilray during the second quarter valued at $33,000. 9.35% of the stock is currently owned by institutional investors and hedge funds.
Tilray Company Profile
(
Get Free Report)
Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Canada.
Read More
Before you consider Tilray, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Tilray wasn't on the list.
While Tilray currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Options trading isn’t just for the Wall Street elite; it’s an accessible strategy for anyone armed with the proper knowledge. Think of options as a strategic toolkit, with each tool designed for a specific financial task. Keep reading to learn how options trading can help you use the market’s volatility to your advantage.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
